JB

Capital in place.Approvals in 34 countries. Indication expansion globally in motion. Pipeline of combination trials cooking. Immunotherapy 2.0. Never give up.

$IBRX ... that was quick ... here the details: "ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy Pipeline • ImmunityBio to receive $75 million in non-dilutive funding under existing Revenue Interest Purchase Agreement (RIPA) with Oberland Capital, bringing total committed capital to $375 million • Simultaneously conversion of $25 million of the outstanding promissory note held by Nant Capital, an entity affiliated with Executive Chairman bolstering ImmunityBio’s balance sheet with reduction in the debt • Proceeds strengthen ImmunityBio’s balance sheet and support global expansion following recent approvals, while advancing company’s broader immunotherapy pipeline."

@LoriMills4CA42 @faruqilaw Big Pharma is behind this. They don’t want this treatment available. Absolutely disgusting.

@faruqilaw How sick. How about we think about the truly ill cancer patients. This is vile. People worried about stock instead of cancer patients. Truly disgusting.

ImmunityBio, Inc. Class Action Lawsuit $IBRX ImmunityBio Deadline: May 26, 2026 Learn More 👉 faruqilaw.com/IBRX #faruqilaw #NASDAQ #NASDAQListed #stocks #stockmarketnews #StocksInNews

@FiveBestBets Combined most of your picks for a great night last night. When you dropping today’s?!

Another winning day yesterday. Tigers +110 💰 Braves -150 💰 Schlitter over 4.5 KOs -110 💰 Alcantara over 1.5 earned runs 💥 Marlins/Dodgers parlay +113 💰 4-1 yesterday up 2.8058 units First 3 days 10-4-1 up 4.7966 units. Great start to baseball!

@davideyoungmd @ActionFixesFear One look at your profile and it easily explains why you would comment such a thing.

$IBRX Update: The IDMC result is in. Yesterday I posted three possible outcomes for the BCG-naive trial. Here's what happened. The Result The Independent Data Monitoring Committee confirmed that N=366 is sufficient to detect clinically meaningful differences between ANKTIVA + BCG and BCG alone. No additional enrollment needed. The supplemental BLA is on track for Q4 2026. This is the "good case" from yesterday's post. The trial wasn't stopped early for overwhelming efficacy. But what PSS chose to publish alongside this announcement tells the real story. The Data They Buried in the PR The Phase 1b patients who started treatment in 2014 - nearly a decade ago: - 6 out of 6 evaluable patients (100%) still in complete remission - Median survival: 8.8 years - Ongoing bladder preservation to date And the 2023 interim analysis of the first 43 randomized patients "demonstrated a difference in durable complete response when ANKTIVA is combined with BCG in the BCG-naive setting." You don't publish 8.8-year survival data and "demonstrated a difference" alongside a sample size confirmation unless you're signaling where the full data is heading. The Consistency Pattern - 2014: 9 patients in Phase 1b, 6 in long-term follow-up → 6/6 (100%) still in remission at 8.8 years - 2023: First 43 randomized patients → "difference in durable CR" between arms - 2026: 366 patients fully enrolled → IDMC confirms adequate power Same result at every scale. Nine patients. Forty-three. Three hundred sixty-six. Where This Fits - Bladder CIS: FDA approved (April 2024) ✓ - Papillary: NCCN 2A + sBLA resubmitted ✓ - BCG-naive: IDMC confirmed, BLA Q4 2026 ✓ ← JUST CONFIRMED - Global: 34 jurisdictions ✓ - NK cell platform: Leonardo assembling ✓ The warning letter dominated the headlines this week. This press release will dominate the story this year. The randomized data the FDA asked for is coming. The 8.8-year durability says it's going to be worth the wait.

@DavidDin @DrPatrick You can’t enjoy the highs if you haven’t experienced the lows. It’s only a matter of time for $IBRX to take off.

$IBRX Today's drop in the share price is no fun. You guys know I am all in, and I can take it. Still — wishing I was smart enough to sell high and buy back lower. Sigh. In my view, @drpatrick and his team had no other choice than what they did. I remember when I discovered ImmunityBio in March 2025. I am a total geek when it comes to new technologies for healthcare, supplements, longevity… and I had never ever heard about ImmunityBio before I listened to Dr. Soon-Shiong on that podcast with Tucker Carlson. In hindsight it is clear to me that management had no other choice than making bold claims to generate interest. Nevertheless, I am convinced that I have never heard them make a single statement that wasn’t true. @drpatrick is an old-school gentleman, and everything he has ever said since I started following him is pure gospel to me. He has never exaggerated anything, and he has never pushed aggressive PR like I would have wished sometimes. He has informed us on X about every single step he was taking with his company, and he has never overpromised. On the contrary, I believe he held back. He knew he had to circumvent the US FDA through the strategic partnership with Saudi, and now the whole world has started approving Anktiva. So he got warning letters from the FDA, and he didn’t react aggressively. So what? A real, world-changing entrepreneur will always choose the route of asking for forgiveness afterwards instead of asking for permission beforehand. He did what he had to do. In my view, he had no other choice. I just checked again what happened in early May 2025, when the US FDA shocked the company with its Refusal to File for the bigger bladder cancer market. At that time the stock tanked about 25% in four straight trading days, and then started a strong rebound after presenting higher-than-expected revenue figures. There are a lot of new investors in ImmunityBio who know little about the company, and a drop like this after such news is normal. I am sure there will soon be some very good news again from @drpatrick. The stock was ready to go to $15. Instead we actually saw the share price re-visit the lower Fibonacci level… Live long and prosper with Anktiva. Show the cancer survivors to the world and let them tell their stories. The public can connect the dots themselves. They will understand that Anktiva can cure cancer without the company having to say it again. Mission accomplished.

Update- I have a prayer request! 6 months after my husbands Terminal diagnosis of Glioblastoma we have his next MRI scheduled tomorrow at 10:00 Pacific. Please pray that there is no new growth and his brain scan is normal again. My husband had to miss his last therapy of #ANKTIVA and NK cell infusion 2 weeks ago as he had the flu. @bullishbruk @tteuscher

@CyndyRhodes2024 @JOKAQARMY1 @grok Definitely is which is why you should be buying up the company stock @ImmunityBio with the ticker $IBRX This will make many millionaires and save so many lives.

@JOKAQARMY1 @Grok Is the information in this video factual?

Cancer cure approved in Saudi Arabia.

@DrMakaryFDA #Anktiva #Ibrx @ImmunityBio @DrPatrick

We’re delivering for cancer patients who have been waiting for game-changing therapies.

@RoundtableSpace @grok can you explain how to set this bot up?

A STUDENT USED ANTHROPIC AI TO TURN ~$1K INTO $1.5M ON POLYMARKET WITH 44K TRADES AND A QUANT-DRIVEN BOT.

@DirtyBubbleBets Lfg

FREE NBA PLAY OF THE DAY ⭐️ My 𝗕𝗼𝘁 will send to everyone who 𝗟𝗜𝗞𝗘𝗦 + 𝗥𝗘𝗣𝗟𝗜𝗘𝗦 (must follow @DirtyBubbleBets) 10-1 (91%) Our Last 11 Freeplays 💎 Game Tips Off At 11:10pm EST ⏰

@RoundtableSpace @grok explain what Claude skills are and how this is beneficial

Anthropic dropped a 33 pages cheat sheet for building Claude skills resources.anthropic.com/hubfs/The-Comp…

$IBRX @ImmunityBio #Bullish #ANKTIVA #Cancer

@DrMakaryFDA @ImmunityBio #ANKTIVA @US_FDA

FDA is moving with unprecedented agility. Today we approved a multiple myeloma drug just 55 days after the application was filed. And last week’s approval (a major leap forward) was approved in 44 days. If a trial result shows immediate promise for many Americans, why wait?

@CHAIRSNIFFING Right! TF is happening. Of course I got him for 6pts and idk wtf is happening

Anyone who’s watching on tv is Isaiah joe even in the game? Is this nigga hurt? He should be coming off the bench raining 3’s but it doesn’t look like he’s played since the first qt?

@jusbeinonlyme @playbook

Okc/knicks account.sportsbook.fanduel.com/sportsbook/add…

@danawhite @Topps #RipItFriday #LFG

Billions invested, decades of research, millions of lives lost: So why can't we cure cancer? This Friday at 8p/7C, join @ChrisCuomo for a live national conversation with the administration’s top doctors and physicians who say they may have the solution to killing cancer. Find us on your screen: NewsNationNow.com

This airs tomorrow on SR

#IBRX #Cancer @US_FDA @RobertKennedyJr